Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us

Egis Sees Sales Rising as Much as 6% Next Year, MTI Reports

Aug. 7 (Bloomberg) -- Egis Nyrt., the Hungarian drugmaker owned by Laboratoires Servier, expects revenue growth to pick up next year on accelerating exports, state news service MTI said, citing Chief Financial Officer Csaba Poroszlai.

Total revenue probably will increase between 4 percent and 6 percent next year in forint terms after a projected sales growth of between 3 percent to 5 percent this year, Poroszlai said, according to MTI.

Domestic sales are expected to drop as much as 10 percent in the 2012/2013 fiscal year, while exports to the Commonwealth of Independent States are set to grow between 8 percent and 12 percent, similarly to Russian sales, Poroszlai said, MTI reported.

To contact the reporter on this story: Edith Balazs in Budapest at ebalazs1@bloomberg.net

To contact the editor responsible for this story: James M. Gomez at jagomez@bloomberg.net

Please upgrade your Browser

Your browser is out-of-date. Please download one of these excellent browsers:

Chrome, Firefox, Safari, Opera or Internet Explorer.